Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
- PMID: 6321357
- DOI: 10.1007/BF01641355
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
Abstract
In conjugational crosses, three Klebsiella pneumoniae strains and one Serratia marcescens strain have been demonstrated to transfer resistance determinants to newer types of cephalosporins. While Klebsiella strains donated cefotaxime, cefamandole and cefuroxime resistance to Escherichia coli K-12 recipients, the genetic analysis of exconjugants after the transfer of plasmids from Serratia strains to Proteus or Salmonella recipients showed that the cefoxitin resistance determinant was also co-transferred. In subsequent transfer cycles of this plasmid, cefotaxime and cefoxitin resistance determinants segregated in contrast to the relative stability of plasmids derived from Klebsiella strains in subsequent transfer cycles. From results obtained in this study, it may be concluded that in some strains of nosocomial Enterobacteriaceae, resistance to newer cephalosporins could be transmissible and thus plasmid-located.
Similar articles
-
Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.Chemotherapy. 1979;25(3):157-61. doi: 10.1159/000237835. Chemotherapy. 1979. PMID: 456076
-
[Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].Zentralbl Bakteriol Orig A. 1979;245(3):312-6. Zentralbl Bakteriol Orig A. 1979. PMID: 44785 German.
-
In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.Microbiol Immunol. 1979;23(10):955-64. doi: 10.1111/j.1348-0421.1979.tb00526.x. Microbiol Immunol. 1979. PMID: 390321
-
Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.Drug Intell Clin Pharm. 1985 Mar;19(3):188-98. doi: 10.1177/106002808501900304. Drug Intell Clin Pharm. 1985. PMID: 3884304 Review.
-
Structure-activity relationships related to ceftizoxime (FK 749).Med Res Rev. 1981 Summer;1(2):127-57. doi: 10.1002/med.2610010202. Med Res Rev. 1981. PMID: 6287129 Review. No abstract available.
Cited by
-
atpD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes of emerging XDR and MDR-Proteus mirabilis.Sci Rep. 2021 May 4;11(1):9476. doi: 10.1038/s41598-021-88861-w. Sci Rep. 2021. PMID: 33947875 Free PMC article.
-
Biochemical characteristics of extended broad spectrum beta-lactamases.Infection. 1989 Nov-Dec;17(6):429-33. doi: 10.1007/BF01645566. Infection. 1989. PMID: 2613337
-
Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.Antimicrob Agents Chemother. 1988 May;32(5):626-30. doi: 10.1128/AAC.32.5.626. Antimicrob Agents Chemother. 1988. PMID: 3293523 Free PMC article.
-
Nucleotide sequence and phylogeny of SHV-2 beta-lactamase.Antimicrob Agents Chemother. 1990 Sep;34(9):1725-32. doi: 10.1128/AAC.34.9.1725. Antimicrob Agents Chemother. 1990. PMID: 2285285 Free PMC article.
-
Outbreak of nosocomial infections due to extended-spectrum beta-lactamase-producing strains of enteric group 137, a new member of the family Enterobacteriaceae closely related to Citrobacter farmeri and Citrobacter amalonaticus.J Clin Microbiol. 2000 Nov;38(11):3946-52. doi: 10.1128/JCM.38.11.3946-3952.2000. J Clin Microbiol. 2000. PMID: 11060050 Free PMC article.